Food-drug interactions frequently hamper oral drug development due to various physicochemical, physiological and formulation-dependent mechanisms. This has …
CW Chiang, S Tang, C Mao, Y Chen - Molecular Pharmaceutics, 2023 - ACS Publications
The incorporation of counterions into amorphous solid dispersions (ASDs) has been proven to be effective for improving the dissolution rates of ionizable drugs in ASDs. In this work, the …
The marketed oral solution of itraconazole (Sporanox®) contains 40%(259.2 mM) of 2- hydroxypropyl-β-cyclodextrin (HP-β-CD). The obvious role of HP-β-CD is to solubilize …
CW Chiang, S Tang, JM Boonstra… - International Journal of …, 2024 - Elsevier
Extemporaneous preparation (EP) formulation is an attractive strategy to accelerate the formulation development of new chemical entities for first entry into human study. In this …
The incorporation of a counterion into an amorphous solid dispersion (ASD) has been proven to be an attractive strategy to improve the drug dissolution rate. In this work, the …
P Bapat, R Schwabe, S Paul, YC Tseng… - Journal of …, 2024 - Elsevier
Abstract Development of a release test for amorphous solid dispersions (ASDs) that is in vivo predictive is essential to identify optimally performing formulations early in …
I Sarcevica, B Hens, I Tomaszewska… - Molecular …, 2023 - ACS Publications
The TIM-1 gastrointestinal model is one of the most advanced in vitro systems currently available for biorelevant dissolution testing. This technology, the initial version of which was …
MJ Dolton, C Bowman, F Ma, S Cheeti… - Journal of …, 2024 - Elsevier
Dynamic in vitro absorption systems and mechanistic absorption modeling via PBPK have both shown promise in predicting human oral absorption, although these efforts have been …